Literature DB >> 7119569

Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with type III hyperlipoproteinemia.

M Fainaru, R W Mahley, R L Hamilton, T L Innerarity.   

Abstract

Cholesteryl ester-rich beta-very low density lipoproteins (beta-VLDL) are beta-migrating lipoproteins that accumulate in the d < 1.006 g/ml fraction of plasma from cholesterol-fed animals and from patients with Type III hyperlipoproteinemia. They can be separated from pre-beta-migrating very low density lipoproteins in the d 1.006 g/ml fraction by Geon-Pevikon block electrophoresis. The beta-VLDL have a general property of stimulating cholesteryl ester synthesis and accumulation in macrophages. In the present study, we demonstrated that beta-VLDL obtained from cholesterol-fed dogs fasted for 16 hr were heterogeneous and that two subpopulations of particles, referred to as Fractions I and II, could be isolated from the whole beta-VLDL fraction using gel filtration chromatography. These fractions of beta-VLDL were similar in that both were cholesteryl ester rich, had beta-electrophoretic mobility on Geon-Pevikon electrophoresis, and possessed the B and E apoproteins as major constituents. However, Fractions I and II differed in size, shape, electrophoretic mobility, chemical composition, and apoprotein B type. (Fraction I vs. Fraction II: size: 90 to 300 nm vs. 20 to 70 nm; shape: irregular with redundant surface vs. spherical; electrophoretic mobility on paper: origin vs. beta; chemical composition: rich in phospholipid and poor in protein vs. rich in protein and poor in triglycerides; apoprotein B types: equal amounts of the high and low molecular weight forms vs. predominantly the high molecular weight form.) Furthermore, Fraction I was 3- to 15-fold more active than Fraction II in stimulating cholesteryl ester formation in mouse peritoneal macrophages. The concentration of Fraction I, but not Fraction II, was diminished in plasma by prolonged fasting, and Fraction I transported more intestinal-absorbed retinol than Fraction II. In addition, the plasma clearance of Fraction I injected into cholesterol-fed dogs was distinctly different from the clearance of Fraction II, and the in vivo dieaway of Fraction I resembled that of chylomicrons and chylomicron remnants. These findings suggest that beta-VLDL in dogs are composed of cholesteryl ester-rich chylomicron remnants (Fraction I) and cholesteryl ester-rich lipoproteins, probably of liver origin (Fraction II). Finally, in studies of two patients with Type III hyperlipoproteinemia, we also identified the existence of two fractions in the beta-VLDL with characteristics similar to Fractions I and II of cholesterol-fed dogs.-Fainaru, M., R. W. Mahley, R. L. Hamilton, and T. L. Innerarity. Structural and metabolic heterogeneity of beta-very low density lipoproteins from cholesterol-fed dogs and from humans with Type III hyperlipoproteinemia.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7119569

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  35 in total

1.  Severe xanthomatosis associated with familial apolipoprotein E deficiency.

Authors:  G Feussner
Journal:  J Clin Pathol       Date:  1996-12       Impact factor: 3.411

2.  Severe type III hyperlipoproteinemia in two patients maintained on chronic hemodialysis.

Authors:  G Feussner; J Bommer; R Ziegler
Journal:  Klin Wochenschr       Date:  1990-01-19

3.  High receptor binding affinity of lipoproteins in atypical dysbetalipoproteinemia (type III hyperlipoproteinemia).

Authors:  D A Chappell
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

4.  A novel electrophoretic variant of human apolipoprotein E. Identification and characterization of apolipoprotein E1.

Authors:  K H Weisgraber; S C Rall; T L Innerarity; R W Mahley; T Kuusi; C Ehnholm
Journal:  J Clin Invest       Date:  1984-04       Impact factor: 14.808

5.  Degradation of lipoproteins by human monocyte-derived macrophages. Evidence for two distinct processes for the degradation of abnormal very-low-density lipoprotein from subjects with type III hyperlipidaemia.

Authors:  A K Soutar; B L Knight
Journal:  Biochem J       Date:  1984-02-15       Impact factor: 3.857

6.  Apolipoprotein E polymorphism influences postprandial retinyl palmitate but not triglyceride concentrations.

Authors:  E Boerwinkle; S Brown; A R Sharrett; G Heiss; W Patsch
Journal:  Am J Hum Genet       Date:  1994-02       Impact factor: 11.025

7.  Characterization of two unique cholesterol-rich lipid particles isolated from human atherosclerotic lesions.

Authors:  F F Chao; E J Blanchette-Mackie; Y J Chen; B F Dickens; E Berlin; L M Amende; S I Skarlatos; W Gamble; J H Resau; W T Mergner
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

8.  Metabolism of apolipoproteins B-48 and B-100 of triglyceride-rich lipoproteins in patients with familial dysbetalipoproteinemia.

Authors:  A F Stalenhoef; M J Malloy; J P Kane; R J Havel
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

9.  Intravenous infusion of apolipoprotein E accelerates clearance of plasma lipoproteins in rabbits.

Authors:  R W Mahley; K H Weisgraber; M M Hussain; B Greenman; M Fisher; T Vogel; M Gorecki
Journal:  J Clin Invest       Date:  1989-06       Impact factor: 14.808

10.  Accelerated transfer of cholesteryl esters in dyslipidemic plasma. Role of cholesteryl ester transfer protein.

Authors:  A Tall; E Granot; R Brocia; I Tabas; C Hesler; K Williams; M Denke
Journal:  J Clin Invest       Date:  1987-04       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.